Veye Lung Nodules

Aidence

This AI assistant supports radiologists with detecting, classifying and tracking the growth of pulmonary nodules. Veye Lung Nodules integrates into the PACS and is currently in use across Europe in both routine clinical practice and lung cancer screening programs.
Product specifications Information source: Vendor
Last updated: April 14, 2021
General
Product name Veye Lung Nodules
Company Aidence
Subspeciality Chest
Modality CT
Disease targeted Lung cancer
Key-features Nodule detection, nodule classification, volume quantification, growth calculation (prior study retrieval)
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion
Data characteristics
Population
Input low or standard dose CT scans, maximum axial slice thickness of 3mm, non-contrast or post-contrast, multi-slice
Input format DICOM
Output image annotations, grayscale presentation state (GSPS), burn-in series, table of quantified values
Output format DICOM, PDF
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 1 - 10 minutes
Certification
CE
Certified, Class IIb
FDA
No or not yet
Market presence
On market since 12-2017
Distribution channels Nuance, Incepto, Sectra
Countries present (clinical, non-research use) 6
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use
Based on Number of scans analysed
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers